Clinical Trials Logo

Sudden Cardiac Death clinical trials

View clinical trials related to Sudden Cardiac Death.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04540354 Withdrawn - Heart Failure Clinical Trials

Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death

PROFID-Reduced
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to demonstrate that in post-MI patients with symptomatic heart failure who receive optimal medical therapy for this condition, and with reduced LVEF ≤ 35% but low risk for SCD according to a personalised risk score, optimal medical therapy without ICD implantation (index group) is not inferior to optimal medical therapy with ICD implantation (control group) with respect to all-cause mortality.

NCT ID: NCT04540289 Withdrawn - Clinical trials for Myocardial Infarction

Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to demonstrate that in post-MI patients with preserved LVEF>35% but high risk for SCD according to a personalised risk score, the implantation of an ICD (index group) is superior to optimal medical therapy (control group) with respect to all-cause mortality.

NCT ID: NCT02113722 Withdrawn - Clinical trials for Sudden Cardiac Death

Is Left Stellate Ganglionectomy Beneficial to Patients With Life Threatening Ventricular Arrhythmias

Reduce-SCD
Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the incidence of recurrent life threatening ventricular arrhythmias in patients with an implanted cardiac defibrillator (ICD) can be reduced if a surgical left stellate ganglionectomy is performed.